The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
Jörger M, Finn S, Cuffe S, Byrne A, Gray S. The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?. Expert Opin Ther Targets 2016; 20:1339-1356.
Jul 11, 2016
The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
Jul 11, 2016
Expert Opin Ther Targets 2016; 20:1339-1356
Jörger Markus, Finn Stephen P, Cuffe Sinead, Byrne Annette T, Gray Steven G
more
